¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary generalised epilepsy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ, ¼Ó¹ß»ý½Ä¼±ÀúÇÏÁõ
  • secondary immune response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • secondary infection
    ÀÌÂ÷°¨¿°, ¼Ó¹ß°¨¿°
  • secondary keratitis
    ¼Ó¹ß°¢¸·¿°
  • secondary lysosome
    ÀÌÂ÷¿ëÇØ¼Òü
  • secondary nodule
    Á¾ÀÚÁß½É, ¹èÁß½É
  • secondary pneumonia
    ¼Ó¹ßÆó·Å
  • secondary process thinking
    ÀÌÂ÷°úÁ¤»ç°í
  • secondary sequestrum
    ÀÌÂ÷ºÎ°ñ, ºÎºÐºÐ¸®Á×Àº»À
  • secondary sex characteristic
    ÀÌÂ÷¼ºÂ¡
  • secondary sexual character
    ÀÌÂ÷¼ºÂ¡
  • secondary shock
    ÀÌÂ÷¼îÅ©, ¼Ó¹ß¼îÅ©
  • secondary sterility
    ¼Ó¹ßºÒÀÓ
  • secondary suture
    ÀÌÂ÷ºÀÇÕ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • morpheic epilepsy
    ¼ö¸éÇü°£Áú
  • myoclonic epilepsy
    °£´ë¼º±Ù°æ·Ã°£Áú
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • nocturnal epilepsy
    ¾ß°£°£Áú
  • organic epilepsy
    ±âÁú¼º°£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ°£Áú
  • photic epilepsy
    ±¤¼±°£Áú, ºûÀ¯¹ß°£Áú
  • photogenic epilepsy
    ±¤¼±°£Áú, ºûÀ¯¹ß°£Áú
  • photosensitive epilepsy
    ±¤¼±¹Î°¨°£Áú, ºû¹Î°¨°£Áú
  • post-apoplectic epilepsy
    ³úÁßdzÈİ£Áú
  • post-stroke epilepsy
    ³úÁßdzÈİ£Áú
  • post-traumatic epilepsy
    ¿Ü»óÈİ£Áú
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • psychomotor epilepsy
    Á¤½Å¿îµ¿°£Áú
  • reflex epilepsy
    ¹Ý»ç°£Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • myoclonus epilepsy
    ¹Ì¿ÀŬ·Î´©½º°£Áú(¡­ÊÖòð).
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú(~ÊÖòð).
  • nocturnal epilepsy
  • organic epilepsy
    ±âÁú¼º °£Áú(ÐïòõàõÊÖòð).
  • peripheral epilepsy
    ¸»Ãʼº °£Áú(¡­àõÊÖòð).
  • petit mal epilepsy
    ¼Ò¹ßÀÛ°£Áú(¡­ÊÖòð).
  • photic epilepsy
    ±¤¼º°£Áú(ÎÃàõÊÖòð).
  • photic epilepsy
    ±¤¼º°£Áú(ÎÃàõÊÖòð)
  • photic reflex epilepsy
    ±¤¹Ý»ç°£Áú(ÎÃÚãÞÒ ÊÖòð).
  • photic reflex epilepsy
    ±¤¹Ý»ç°£Áú(ÎÃÚãÞÒÊÖòð)
  • photogenic epilepsy
    ¹ß±¤¼º °£Áú(¡­ÊÖòð).
  • photosensitive epilepsy
    °¨±¤¼º(ÊïÎÃàõ) °£Áú
  • postapoplectic epilepsy
    (³ú)Á¹ÁßÈİ£Áú(¡­ý­ÊÖòð).
  • postapoplectic epilepsy
    (³ú)Á¹ÁßÈİ£Áú((Òà)ðïñéý­ÊÖòð)
  • posttraumatic epilepsy
    ¿Ü»óÈÄ °£Áú.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
sHPT secondary hyperparathyroidism
SIMS secondary ion mass spectroscopy
SL sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen...
SMDS secondary myelodysplastic syndrome
SPH secondary pulmonary hemosiderosis; severely and profoundly handicapped; spherocyte; spherocytosis; s...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SP Secondary progressive
ToF-SIMS Time of Flight Secondary Ion Mass Spectrometry
SE secondary electron
SHPT secondary hyperparathyroidism
SMC secondary mesenchyme cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • secondary source
    ÀÌÂ÷ ¿äÀÎ
  • secondary sterility
    ¼Ó¹ß ºÒÀÓ
  • secondary structure
    ÀÌÂ÷ ±¸Á¶
  • secondary syphilis
    ÀÌÂ÷ ¸Åµ¶, 2±â ¸Åµ¶
    s
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • secondary tuberculosis
    ÀÌÂ÷¼º °áÇÙ
  • secondary vaccinia
    ÀÌÂ÷ ¹é½Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
childhood absence epilepsy A generalised epilepsy syndrome characterised by the onset of absence seizures in childhood, typically at age six or seven years. There is a strong genetic predisposition and girls are affected more often than boys. EEG reveals generalised 3 Hz spike-wave activity on a normal background. Prognosis for remission is good if the patient does not also have generalised tonic-clonic seizures.
See: absence.
Synonym: petit mal epilepsy, pyknolepsy.
(05 Mar 2000)
childhood epilepsy with occipital paroxysms A benign epilepsy syndrome characterised by frequent occipital spikes often activated by eye closure. It has a seizure semiology that includes visual manifestations; not always remitting later in life.
(05 Mar 2000)
petit mal epilepsy A generalised epilepsy syndrome characterised by the onset of absence seizures in childhood, typically at age six or seven years. There is a strong genetic predisposition and girls are affected more often than boys. EEG reveals generalised 3 Hz spike-wave activity on a normal background. Prognosis for remission is good if the patient does not also have generalised tonic-clonic seizures.
See: absence.
Synonym: petit mal epilepsy, pyknolepsy.
(05 Mar 2000)
rolandic epilepsy A benign, autosomal, dominant form of epilepsy occurring in children, characterised clinically by arrest of speech, by muscular contractions of the side of the face and arm and epileptic discharges electroencephalographically.
Origin: Luigi Rolando
(05 Mar 2000)
pharmacoresistent epilepsy Epilepsy not adequately controlled by medication.
Synonym: pharmacoresistent epilepsy.
(05 Mar 2000)
photogenic epilepsy A form of reflex epilepsy precipitated by light.
(05 Mar 2000)
complex precipitated epilepsy A form of reflex epilepsy initiated by specialised sensory stimuli, e.g., certain visual patterns.
(05 Mar 2000)
cortical epilepsy Epilepsy of various aetiologies characterised by focal seizures or secondarily generalised tonic-clonic seizures. Ictal symptoms are often related to the brain region where the seizure begins focally.
Synonym: cortical epilepsy, local epilepsy, partial epilepsy.
(05 Mar 2000)
myoclonic astatic epilepsy A petit mal variant characterised by atonic (drop attacks) and tonic or tonic-clonic attacks in neurologically disabled (hemiplegic, ataxic, etc.) children with mental retardation; characterised in EEG by 2/sec spike and wave discharges; usually progresses in spite of medication.
(05 Mar 2000)
myoclonus epilepsy A clinically diverse group of epilepsy syndromes, some benign, some progressive. Many are hereditary with mendelian and nonmendelian mitochondrial inheritance. All are characterised by the occurrence of myoclonus, which may be limited or predominate in the condition. Specific syndromes include cherry red spot myoclonus syndrome, ceroid lipofuscinosis, myoclonic epilepsy with ragged red fibres, and Baltic myoclonus.
Synonym: localization related epilepsy.
(05 Mar 2000)
cryptogenic epilepsy tonic-clonic seizure
posttraumatic epilepsy A convulsive state following and causally related to head injury; with brain damage either manifested clinically or ascertained by special examinations such as computed tomography. To assume causal relationship, the individual must have had no previous epilepsy, no cerebral disease, and no other brain trauma. The attacks should have started, depending on the severity of the wounding, within 3 months to 2 years of the alleged trauma and be of a type compatible with the site of injury and the EEG abnormalities.
(05 Mar 2000)
procursive epilepsy A psychomotor attack initiated by whirling or running.
(05 Mar 2000)
psychomotor epilepsy Attacks with elaborate and multiple sensory, motor, and/or psychic components, the common feature being a clouding or loss of consciousness and amnesia for the event; clinical manifestations may take the form of automatisms; emotional outbursts of temper, anger or show of fear; motor or psychic disturbances; or may be related to any sphere of human activity. Electroencephalographically, the attack is characterised by spike discharges in the temporal lobe, especially in sleep.
See: procursive epilepsy, visceral epilepsy, uncinate epilepsy.
Synonym: automatic epilepsy, psychomotor seizure.
(05 Mar 2000)
sensory epilepsy Focal epilepsy initiated by a somatosensory phenomenon.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á